naltrexone has been researched along with bam 22p in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bouvier, M; Breit, A; Devi, LA; Gagnidze, K; Lagacé, M | 1 |
1 other study(ies) available for naltrexone and bam 22p
Article | Year |
---|---|
Simultaneous activation of the delta opioid receptor (deltaOR)/sensory neuron-specific receptor-4 (SNSR-4) hetero-oligomer by the mixed bivalent agonist bovine adrenal medulla peptide 22 activates SNSR-4 but inhibits deltaOR signaling.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Cells, Cultured; Endocytosis; Enkephalin, Methionine; Ganglia, Spinal; Humans; Naltrexone; Neurons, Afferent; Protein Kinase C; Protein Precursors; Rats; Rats, Long-Evans; Receptors, G-Protein-Coupled; Receptors, Opioid, delta; Signal Transduction | 2006 |